Technology

A coating of selenium nanoparticles significantly reduces the growth of Staphylococcus aureus on polycarbonate, a material common in implanted devices such as catheters and endotracheal tubes, engineers at Brown University report in a new study.

Boston Scientific Corporation has announced a significant milestone for its telemonitoring technology with the initial use of the Latitude NXT Remote Patient Management System for pacemaker patients in Europe. The company says its next-generation wireless remote patient management system enables physicians to risk-stratify patients and more confidently make treatment decisions.

A new clinical study suggests endoscopic ablation for Atrial fibrillation generates good results with a durable outcome and a short learning curve for operators.

NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo pathology, has announced that it has gained CE mark approval for the NvisionVLE™ Imaging System.

iBGStar from Sanofi gets a rave review from imedicalapps, so we thought our readers would like to see us following the progress of a device we’ve been watching for a while.

Supermaterial Graphene may have found another application as researchers at Princeton University tell us about their new “Tooth Tattoo” capable of detecting tiny traces of harmful bacteria.

3D Systems Corporation has announced that it has acquired San Francisco start-up Bespoke Innovations™, Inc. Bespoke develops proprietary, integrated scan, design and print technology that is designed to deliver custom fit prosthetics, orthotics and orthopedic devices that improve treatment and lifestyle outcomes.

Elsevier Business Intelligence (EBI), publisher of “The Gray Sheet”, is holding its IN³ Medical Device 360° at the Hyatt Regency Boston, June 27-29 2012.

State of the art materials lie at the heart of this incredibly liberating exoskeleton for people with spinal cord injuries. The definition of a medical device, for CE mark purposes stretches from cranberry pills to exoskeletons it seems as Ekso Bionics announces gaining of clearance to market in Europe.

Merit Medical Systems will be recruiting up to 200 staff over the next five years at its newly opened €20M Galway facility, already an employer of 379. The aim is to make the facility the company’s centre of excellence for new product and technology development.

It’s EuroPCR week, so cardiothoracic companies are timing their press announcements to coincide with the event. Californian company Elixir Medical’s fully bioabsorbable drug eluting coronary scaffold has been the subject of what looks like a very promising clinical study presented during the event.

We’d not heard of them, but it appears that Orthopedic Synergies Inc’s burgeoning portfolio of companies including OMNILife sciences Inc, have been quietly getting on with developing and implanting their computer assisted Apex knee replacement to the tune of 1000 patients.

Biomedical Structures LLC reckons its newly-unveiled high-precision tapering textiles could be used to create more lifelike synthetic scaffolds

Direct injection of stem cells and other biotherapeutics into the myocardium is quite a hot topic, so the announcement of an optimised injection catheter must be well timed.

Biotronik ticks another big box with the FDA clearance of its Lumax 740 ICDs and CRT-Ds equipped with home monitoring, supporting the company’s claim to have the only CE and FDA approved remote cardiac patient management system for early detection of clinically relevant events.

Filtration device specialist Nephros, Inc., has announced FDA 510(k) clearance to market its Hemodiafiltration (“HDF”) system for the treatment of chronic renal failure when used with UF controlled dialysis machines capable of producing ultrapure dialysate.